Differential effects of TGF-β isoforms on murine fetal dural cells and calvarial osteoblasts

Plastic and Reconstructive Surgery

Volumn 120, Issue 3, 2007, Pages 614-624

  Cabiling, David S ^a   Kim, Elizabeth ^a   Yan, David ^a   Jacob, Shushan ^a   Nah, Hyun Duck ^a   Kirschner, Richard E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MATRIX; CALVARIA; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DURA MATER; DURAL CELL; FETUS; GENE EXPRESSION PROFILING; MORPHOGENESIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; CELLS, CULTURED; DURA MATER; FETUS; MICE; OSTEOBLASTS; PROTEIN ISOFORMS; SKULL; TRANSFORMING GROWTH FACTOR BETA;

EID: 34547924095     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000270292.89388.a3     Document Type: Article

References (73)

1. Cohen, M. M., Jr. Transforming growth factor betas and fibroblast growth factors and their receptors: Role in sutural biology and craniosynostosis. J. Bone Miner. Res. 12: 322, 1997.
2. Centrella, M., Horowitz, M. C., Wozney, J. M., and McCarthy, T. L. Transforming growth factor-beta gene family members and bone. Endocr. Rev. 15: 27, 1994.
3. Baylink, D. J., Finkelman, R. D., and Mohan, S. Growth factors to stimulate bone formation. J. Bone Miner. Res. 8 Suppl. 2: S565, 1993.
4. Mohan, S., and Baylink, D. J. Bone growth factors. Clin. Orthop. Relat. Res. 263: 30, 1991.
5. Centrella, M., McCarthy, T. L., and Canalis, E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J. Biol. Chem. 262: 2869, 1987.
6. Centrella, M., McCarthy, T. L., and Canalis, E. Skeletal tissue and transforming growth factor beta. F.A.S.E.B.J. 2: 3066, 1988.
7. Murata, H., Zhou, L., Ochoa, S., Hasan, A., Badiavas, E., and Falanga, V. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J. Invest. Dermatol. 108: 258, 1997.
8. Bonewald, L. Transforming growth factor beta. In J. Bilzekian, L. Raisz, and G. Rodan (Eds.), Principles of Bone Biology. San Diego: Academic Press, 1996. Pp. 903-918.
9. Bonewald, L. F., and Dallas, S. L. Role of active and latent transforming growth factor beta in bone formation. J. Cell. Biochem. 55: 350, 1994.
10. Linkhart, T. A., Mohan, S., and Baylink, D. J. Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 19: 1S, 1996.
11. Noda, M., and Camilliere, J. J. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124: 2991, 1989.
12. Beck, L. S., Deguzman, L., Lee, W. P., et al. TGF-beta 1 induces bone closure of skull defects. J. Bone Miner. Res. 6: 1257, 1991.
13. Beck, L. S., Amento, E. P., Xu, Y., et al. TGF-beta 1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. J. Bone Miner. Res. 8: 753, 1993.
14. Most, D., Levine, J. P., Chang, J., et al. Studies in cranial suture biology: Up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast. Reconstr. Surg. 101: 1431, 1998.
15. Roth, D. A., Longaker, M. T., McCarthy, J. G. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion. J. Bone Miner. Res. 12: 311, 1997.
16. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: Implications for suture fusion and patency. J. Bone Miner. Res. 15: 2413, 2000.
17. Mehrara, B. J., Spector, J. A., Greenwald, J. A., Ueno, H., and Longaker, M. T. Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plast. Reconstr. Surg. 110: 506, 2002.
18. Spector, J. A., Greenwald, J. A., Warren, S. M., et al. Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation. Plast. Reconstr. Surg. 109: 631, 2002.
19. Song, H. M., Fong, K. D., Nacamuli, R. P., et al. Mechanisms of murine cranial suture patency mediated by a dominant negative transforming growth factor-beta receptor adenovirus. Plast. Reconstr. Surg. 113: 1685, 2004.
20. Pelton, R. W., Saxena, B., Jones, M., Moses, H. L., and Gold, L. I. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115: 1091, 1991.
21. Levine, J. H., Moses, H. L., Gold, L. I., and Nanney, L. B. Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am. J. Pathol. 143: 368, 1993.
22. Bottinger, E. P., and Kopp, J. B. Lessons from TGF-beta transgenic mice. Miner. Electrolyte Metab. 24: 154, 1998.
23. Nugent, P., Ma, L., and Greene, R. M. Differential expression and biological activity of retinoic acid-induced TGFbeta isoforms in embryonic palate mesenchymal cells. J. Cell. Physiol. 177: 36, 1998.
24. Sanford, L. P., Ormsby, I., Gittenberger-de Groot, A. C., et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124: 2659, 1997.
25. Roth, D. A., Gold, L. I., Han, V. K., et al. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast. Reconstr. Surg. 99: 300, 1997.
26. Mehrara, B. J., Most, D., Chang, J., et al. Basic fibroblast growth factor and transforming growth factor beta-1 expression in the developing dura mater correlates with calvarial bone formation. Plast. Reconstr. Surg. 104: 435, 1999.
27. Opperman, L. A., Nolen, A. A., and Ogle, R. C. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J. Bone Miner. Res. 12: 301, 1997.
28. Poisson, E., Sciote, J. J., Koepsel, R., Cooper, G. M., Opperman, L. A., and Mooney, M. P. Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. Cleft Palate Craniofac. J. 41: 392, 2004.
29. Kirschner, R. E., Gannon, F. H., Xu, J., et al. Craniosynostosis and altered patterns of fetal TGF-beta expression induced by intrauterine constraint. Plast. Reconstr. Surg. 109: 2338, 2002.
30. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747, 1997.
31. Komori, T., Yagi, H., Nomura, S., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755, 1997.
32. Mundlos, S., Otto, F., Mundlos, C., et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773, 1997.
33. Otto, F., Thornell, A. P., Crompton, T., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765, 1997.
34. Bialek, P., Kern, B., Yang, X., et al. A twist code determines the onset of osteoblast differentiation. Dev. Cell 6: 423, 2004.
35. Mazzali, M., Kipari, T., Ophascharoensuk, V., Wesson, J. A., Johnson, R., and Hughes, J. Osteopontin: A molecule for all seasons. Q. J. Med. 95: 3, 2002.
36. Sodek, J., Ganss, B., and McKee, M. D. Osteopontin. Crit. Rev. Oral Biol. Med. 11: 279, 2000.
37. Ganss, B., Kim, R. H., and Sodek, J. Bone sialoprotein. Crit. Rev. Oral Biol. Med. 10: 79, 1999.
38. Opperman, L. A., Passarelli, R. W., Morgan, E. P., Reintjes, M., and Ogle, R. C. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J. Bone Miner. Res. 10: 1978, 1995.
39. Roth, D. A., Bradley, J. P., Levine, J. P., McMullen, H. F., McCarthy, J. G., and Longaker, M. T. Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast. Reconstr. Surg. 97: 693, 1996.
40. Bradley, J. P., Levine, J. P., McCarthy, J. G., and Longaker, M. T. Studies in cranial suture biology: Regional dura mater determines in vitro cranial suture fusion. Plast. Reconstr. Surg. 100: 1091, 1997.
41. Opperman, L. A., Chhabra, A., Cho, R. W., and Ogle, R. C. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro. J. Craniofac. Genet. Dev. Biol. 19: 164, 1999.
42. Chong, S. L., Mitchell, R., Moursi, A. M., et al. Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgf-beta 3) in rabbits with delayed-onset craniosynostosis. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 274: 962, 2003.
43. Opperman, L. A., Moursi, A. M., Sayne, J. R., and Wintergerst, A. M. Transforming growth factor-beta 3(Tgf-beta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. Anat. Rec. 267: 120, 2002.
44. Spector, J. A., Mehrara, B. J., Greenwald, J. A., et al. A molecular analysis of the isolated rat posterior frontal and sagittal sutures: Differences in gene expression. Plast. Reconstr. Surg. 106: 852, 2000.
45. Mehrara, B. J., Steinbrech, D. S., Saadeh, P. B., Gittes, G. K., and Longaker, M. T. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann. Plast. Surg. 42: 502, 1999.
46. Tremollieres, F. A., Strong, D. D., Baylink, D. J., and Mohan, S. Insulin-like growth factor II and transforming growth factor beta 1 regulate insulin-like growth factor I secretion in mouse bone cells. Acta Endocrinol. (Copenh.) 125: 538, 1991.
47. ten Dijke, P., Iwata, K. K., Goddard, C., et al. Recombinant transforming growth factor type beta 3: Biological activities and receptor-binding properties in isolated bone cells. Mol. Cell. Biol. 10: 4473, 1990.
48. Opperman, L. A., Adab, K., and Gakunga, P. T. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev. Dyn. 219: 237, 2000.
49. Frenkel, S. R., Grande, D. A., Collins, M., and Singh, I. J. Fibroblast growth factor in chick osteogenesis. Biomaterials 11: 38, 1990.
50. Frenkel, S. R., Herskovits, M. S., and Singh, I. J. Fibroblast growth factor: Effects on osteogenesis and chondrogenesis in the chick embryo. Acta Anat. (Basel) 145: 265, 1992.
51. Mayahara, H., Ito, T., Nagai, H., et al. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 9: 73, 1993.
52. Stein, G. S., and Lian, J. B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14: 424, 1993.
53. Geng, Y., and Weinberg, R. A. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. U.S.A. 90: 10315, 1993.
54. Ewen, M. E., Sluss, H. K., Whitehouse, L. L., and Livingston, D. M. TGFbeta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74: 1009, 1993.
55. Ko, T. C., Sheng, H. M., Reisman, D., Thompson, E. A., and Beauchamp, R. D. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene 10: 177, 1995.
56. Dennler, S., Goumans, M. J., and ten Dijke, P. Transforming growth factor beta signal transduction. J. Leukoc. Biol. 71: 731, 2002.
57. Graham, J. M., Jr., Badura, R. J., and Smith, D. W. Coronal craniostenosis: Fetal head constraint as one possible cause. Pediatrics 65: 995, 1980.
58. Graham, J. M., Jr., deSaxe, M., and Smith, D. W. Sagittal craniostenosis: Fetal head constraint as one possible cause. J. Pediatr. 95: 747, 1979.
59. Graham, J. M., Jr., and Smith, D. W. Metopic craniostenosis as a consequence of fetal head constraint: Two interesting experiments of nature. Pediatrics 65: 1000, 1980.
60. Higginbottom, M. C., Jones, K. L., and James, H. E. Intrauterine constraint and craniosynostosis. Neurosurgery 6: 39, 1980.
61. Lin, K. Y., Nolen, A. A., Gampper, T. J., Jane, J. A., Opperman, L. A., and Ogle, R. C. Elevated levels of transforming growth factors beta 2 and beta 3 in lambdoid sutures from children with persistent plagiocephaly. Cleft Palate Craniofac. J. 34: 331, 1997.
62. Fong, K. D., Warren, S. M., Loboa, E. G., et al. Mechanical strain affects dura mater biological processes: Implications for immature calvarial healing. Plast. Reconstr. Surg. 112: 1312, 2003.
63. Hunenko, O., Karmacharya, J., Ong, G., and Kirschner, R. E. Toward an understanding of nonsyndromic craniosynostosis: Altered patterns of TGF-beta receptor and FGF receptor expression induced by intrauterine head constraint. Ann. Plast. Surg. 46: 546, 2001.
64. Cohen, M. M., Jr. TGF beta/Smad signaling system and its pathologic correlates. Am. J. Med. Genet. A 116: 1, 2003.
65. Locci, P., Baroni, T., Pezzetti, F., et al. Differential in vitro phenotype pattern, transforming growth factor-beta(1) activity and mRNA expression of transforming growth factor-beta(1) in Apert osteoblasts. Cell Tissue Res. 297: 475, 1999.
66. Fagenholz, P. J., Warren, S. M., Greenwald, J. A., et al. Osteoblast gene expression is differentially regulated by TGF-beta isoforms. J. Craniofac. Surg. 12: 183, 2001.
67. Opperman, L. A., Galanis, V., Williams, A. R., and Adab, K. Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration. Orthod. Craniofac. Res. 5: 5, 2002.
68. Kim, S. J., Angel, P., Lafyatis, R., et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10: 1492, 1990.
69. Frenz, D. A., Liu, W., Williams, J. D., et al. Induction of chondrogenesis: Requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 120: 415, 1994.
70. Sobue, T., Gravely, T., Hand, A., et al. Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells. J. Bone Miner. Res. 17: 502, 2002.
71. Hurley, M. M., Abreu, C., Gronowicz, G., Kawaguchi, H., and Lorenzo, J. Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J. Biol. Chem. 269: 9392, 1994.
72. Greenwald, J. A., Mehrara, B. J., Spector, J. A., et al. In vivo modulation of FGF biological activity alters cranial suture fate. Am. J. Pathol. 158: 441, 2001.
73. Noda, M., and Vogel, R. Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells. J. Cell Biol. 109: 2529, 1989.